LicianPro

ASBPW stock

Aspire Biopharma Holdings, Inc. (ASBPW) short interest & short volume · 0.4% of float short

Aspire Biopharma Holdings, Inc. official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.

What changed

ASBPW short interest was little changed at 5K shares in the Oct 15, 2026 report (0.4% of float, 187.5 days to cover). Daily short volume averaged 48.7% of volume over the last 20 sessions, down from 62.7% the 20 sessions before, the 5th percentile of its own 20-day averages since Sep 16, 2025.

Short interest

Official, twice monthly · settled Oct 15, 2026

Shares short
5K
prior 5K
% of float
0.4%
float 1.2M
Days to cover
187.5
avg vol 26
Change vs prior report
0.0%

6 reports

The last 24 reports (about a year) with Lician Pro.Start 3-day trial — $149/yr

Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.

% of float uses the current float for every report (no float was stored with older reports).

Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026

Daily short volume

Share of each day's volume sold short · FINRA Reg SHO

Latest (Oct 14)
100.0%
36 of 36
20-day average
48.7%
prior 62.7%
Percentile vs own history
5th
127 periods since 2025

Loading prices…

Short volumeRest of the day's volume

Source: FINRA Reg SHO daily short sale volume · Latest Oct 14, 2026

Short squeeze score (model)

Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.

ASBPW's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr

Market-wide: most shorted stocks, biggest changes and unusual short volume · ASBPW overview

Last 10 sessions · daily short volume · FINRA Reg SHO
DateShortTotalShort % of volume
2026-10-143636100.0%
2026-09-281,5005,64926.6%
2026-09-115559.1%
2026-09-0893862.3%
2026-09-045050100.0%
2026-09-014,1124,112100.0%
2026-08-284,2255,72573.8%
2026-08-2790010,3008.7%
2026-08-25429,4720.4%
2026-08-24507486.7%

Healthcare peers with similar quant ratings

ASBPW among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works

ASBPW short interest FAQ

What is ASBPW's short interest?

Aspire Biopharma Holdings, Inc. (ASBPW) had 5K shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report, 0.4% of its 1.2M-share float.

How many days to cover does ASBPW have?

187.5 days: 5K shares short divided by an average daily volume of 26 for the Oct 15, 2026 period.

Is ASBPW short interest rising or falling?

ASBPW short interest was little changed (0.0%) from 5K to 5K shares in the Oct 15, 2026 report.

Is ASBPW a short squeeze candidate?

Lician's squeeze watch scores ASBPW 26 out of 100 (low) from the Oct 15, 2026 report: short interest % of float 0.5/40, days to cover 25/25, change in short interest vs prior report 0/15. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.

What share of ASBPW daily volume is sold short?

48.7% on average over the last 20 sessions to Oct 14, 2026 (FINRA Reg SHO daily short volume; the 5th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.

What was ASBPW's latest FINRA short volume?

On Oct 14, 2026, cached FINRA short volume for Aspire Biopharma Holdings, Inc. (ASBPW) was 36 shares, 100.0% of 36 total volume.

How many ASBPW short-volume sessions are listed on this page?

This page lists 10 cached FINRA short-volume sessions for Aspire Biopharma Holdings, Inc. (ASBPW), from Aug 24, 2026 through Oct 14, 2026.

How did ASBPW short volume percent change from the prior cached session?

Cached FINRA short volume for Aspire Biopharma Holdings, Inc. (ASBPW) moved from 26.6% on Sep 28, 2026 to 100.0% on Oct 14, 2026, up 73.4 percentage points.

Not investment advice. Figures as filed or reported, not a live feed.